Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Jia Xie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|February 10, 2010
[Effect of cyclic strain on cell morphology, viability and proliferation of human dental pulp cells in vitro]Jing Yu, Ya-jia Xie, Duo Xu, et al.
Vaccines|February 28, 2023
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid TumorYa-Jia Xie, Wen-Qian Liu, Dan Li, et al.
Pharmacological Research|April 5, 2024
Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumorsYa-Jia Xie, Sha Tian, Min Huang, et al.
Chinese Medicine|July 16, 2020
Current strategies against COVID-19Shahid Hussain, Ya-Jia Xie, Dan Li, et al.
BMC Medicine|December 9, 2022
Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancerYi-Han Zuo, Wei-Na Gao, Ya-Jia Xie, et al.
Heliyon|June 12, 2023
DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathwayXiao-Ping Zhao, Xiao-Li Zheng, Min Huang, et al.
Pharmacological Research|June 6, 2022
Bacteria-based nanodrug for anticancer therapyYa-Jia Xie, Min Huang, Dan Li, et al.
Pharmacological Research|May 29, 2020
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathwayYa-Jia Xie, Wei-Na Gao, Qi-Biao Wu, et al.
Pharmacological Research|August 14, 2020
Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathwayWen-Jun Wang, Long-Fei Mao, Huan-Ling Lai, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 19, 2020
Evodiamine suppresses non-small cell lung cancer by elevating CD8<sup>+</sup> T cells and downregulating the MUC1-C/PD-L1 axisZe-Bo Jiang, Ju-Min Huang, Ya-Jia Xie, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|February 10, 2010
[Effect of cyclic strain on cell morphology, viability and proliferation of human dental pulp cells in vitro]Jing Yu, Ya-jia Xie, Duo Xu, et al.
Vaccines|February 28, 2023
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid TumorYa-Jia Xie, Wen-Qian Liu, Dan Li, et al.
Pharmacological Research|April 5, 2024
Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumorsYa-Jia Xie, Sha Tian, Min Huang, et al.
Chinese Medicine|July 16, 2020
Current strategies against COVID-19Shahid Hussain, Ya-Jia Xie, Dan Li, et al.
BMC Medicine|December 9, 2022
Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancerYi-Han Zuo, Wei-Na Gao, Ya-Jia Xie, et al.
Heliyon|June 12, 2023
DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathwayXiao-Ping Zhao, Xiao-Li Zheng, Min Huang, et al.
Pharmacological Research|June 6, 2022
Bacteria-based nanodrug for anticancer therapyYa-Jia Xie, Min Huang, Dan Li, et al.
Pharmacological Research|May 29, 2020
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathwayYa-Jia Xie, Wei-Na Gao, Qi-Biao Wu, et al.
Pharmacological Research|August 14, 2020
Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathwayWen-Jun Wang, Long-Fei Mao, Huan-Ling Lai, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 19, 2020
Evodiamine suppresses non-small cell lung cancer by elevating CD8<sup>+</sup> T cells and downregulating the MUC1-C/PD-L1 axisZe-Bo Jiang, Ju-Min Huang, Ya-Jia Xie, et al.
Pageof 2